← Scroll for more →
XOMA Royalty Corp (XOMA)
Pharmaceutical Preparations
Latest Price
$40.17
TTM P/E
25.59
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
7.81
P/B Ratio
5.14
Valuation metrics
adjust assumptions →EPS: $1.46
Book value / share: $7.08
Formula: √(22.5 × EPS × BVPS)
Graham Number
$15.25
62% downside
EPS: $1.46
Target P/E: 26×
Formula: EPS × P/E
P/E Fair Value
$37.96
6% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Bvf Inc | 7.59M | $322.0M | 63.76% | +5.00M | 2026-06-30 |
| Morgan Stanley | 1.70M | $72.0M | 14.25% | -5.0K | 2026-06-30 |
| FMR LLC | 1.61M | $68.0M | 13.48% | +302.6K | 2026-06-30 |
| Woodline Partners LP | 1.11M | $47.0M | 9.36% | +474.4K | 2026-06-30 |
| Newtyn Management, LLC | 709.2K | $30.0M | 5.96% | -- | 2026-06-30 |
| BlackRock, Inc. | 692.0K | $29.0M | 5.81% | +45.1K | 2026-06-30 |
| Vanguard Capital Management LLC | 505.2K | $21.0M | 4.24% | -44.6K | 2026-06-30 |
| Opaleye Management Inc. | 338.4K | $14.0M | 2.84% | +38.4K | 2026-06-30 |
| Geode Capital Management, LLC | 245.3K | $10.0M | 2.06% | +15.6K | 2026-06-30 |
| Water Island Capital LLC | 242.0K | $10.0M | 2.03% | -- | 2026-06-30 |